Drug Trial Radar · NCT04752774
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
Last checked: Nov 19, 2026Latest source record: Jul 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
240
Planned (sponsor's estimate)
Start
Apr 29, 2021
Primary completion
Mar 30, 2029
Study completion Mar 30, 2029
Sponsor
- Lead sponsor
- IpsenIndustry
- Sponsor type
- Industry
- First posted
- Feb 12, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess the safety and efficacy of increasing doses of Corabotase (also known as IPN10200) with the aim to evaluate the Pharmacodynamics (PD) profile of Corabotase and to establish the total Corabotase doses(s) that offer the best efficacy/safety profile when used for the treatment of Adult upper limb (AUL) spasticity.
Conditions
- Spasticity
Interventions
CorabotaseBiological
Powder and solvent for solution for injection
PlaceboDrug
Powder and solvent for solution for injection
DysportBiological
Powder for solution for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of participants with treatment emergent adverse events (TEAEs).Time frame: From baseline until the end of study (9 months)
- Percentage of participants with adverse events of special interest (AESI).Time frame: From baseline until the end of study (9 months)
- Change from baseline in vital sign parameter (blood pressure)Time frame: 9 months
- Change from baseline in vital sign parameter (Heart rate)Time frame: 9 months
- Change from baseline in clinical laboratory test results.Time frame: 9 months
- Presence of IPN10200 and BoNT-A antibodies (binding and neutralising)Time frame: From baseline until the end of study (9 months)
- Change from baseline in physical examination findings.Time frame: 9 months
Locations
81 sites in 14 countries. Site status is shown where the registry gives one.
Rancho Los Amigos National Rehab
Downey, California · Recruiting
Kansas Institute of Research
Overland Park, Kansas · Recruiting
Quest Research Institute
Farmington Hills, Michigan · Terminated
Einstein Physical Medicine and Rehabilitation at Elkins Park
Elkins Park, Pennsylvania · Recruiting
The University of Texas Southwestern Medical Center
Dallas, Texas · Recruiting
Medical University Innsbruck, Department of Neurology
Innsbruck, Austria · Recruiting
Kepler University Hospital GmbH, Department of Neurology and Psychiatry
Linz, Austria · Recruiting
Brothers of Charity Hospital Linz, Department of Neurology I
Linz, Austria · Recruiting
Medical University Vienna, Department of Neurology
Vienna, Austria · Withdrawn
Multiprofile Hospital for Active Treatment "Heart and Brain"
Pleven, Bulgaria · Withdrawn
Medical Center "Rusemed" EOOD
Rousse, Bulgaria · Recruiting
Multiprofile Hospital for Active Treatment of Neurology and Psychiatry "Sveti Naum", Sofia, Neurological Diseases Clinic for Neurodegenerative and Peripheral Neurological Diseases
Sofia, Bulgaria · Recruiting
Diagnostic Consulting Center - Convex EOOD
Sofia, Bulgaria · Recruiting
Medical Center Medica Plus Ltd
Veliko Tarnovo, Bulgaria · Recruiting
University Hospital Hradec Kralove, Clinic of Neurology
Hradec Králové, Czechia · Withdrawn
Hospital Jihlava, Department of Neurology
Jihlava, Czechia · Recruiting
University Hospital Ostrava, Clinic of Neurology, Center for Demyelinating diseases
Ostrava, Czechia · Recruiting
Regional Hospital Pardubice, Clinic of Neurology
Pardubice, Czechia · Recruiting
University Hospital Kralovske Vinohrady, Clinic of Neurology
Prague, Czechia · Withdrawn
General University Hospital in Prague, Clinic of Neurology
Prague, Czechia · Recruiting
Bastia Hospital Center
Bastia, France · Not yet recruiting
Bordeaux University Hospital Center - Pellegrin Hospital Group
Bordeaux, France · Not yet recruiting
Brest University Hospital Center - Morvan Hospital
Brest, France · Not yet recruiting
Raymond-Poincare Hospital - APHP
Garches, France · Not yet recruiting
University Hospital Bonn, Clinic and Policlinic for Neurology
Bonn, Germany · Recruiting
Heinrich Heine University Medical Center, Department of Neurology
Düsseldorf, Germany · Terminated
University Medicine Goettingen, Department of Neurology
Goettigen, Germany · Withdrawn
University Hospital Hamburg-Eppendorf, Clinic and Polyclinic of Neurology
Hamburg, Germany · Recruiting
University Hospital Johannes Gutenberg - University of Mainz, Clinic and Polyclinic of Neurology
Mainz, Germany · Terminated
Ludwig Maximilians University Hospital, Campus Grosshadern, Department of Neurology
Munich, Germany · Withdrawn
GFO Clinics Troisdorf, St. Johannes Sieglar
Troisdorf, Germany · Recruiting
University Hospital Tuebingen, Department of Neurology
Tübingen, Germany · Recruiting
Semmelweis University, Rehabilitation Clinic, Rehabilitation Department of Brain Injuries
Budapest, Hungary · Recruiting
University of Debrecen Clinical Center, Department of Medical Rehabilitation and Physical Medicine
Debrecen, Hungary · Recruiting
Petz Aladar University Teaching Hospital, Department of Neurology
Győr, Hungary · Recruiting
Szent Damjan Greek Catholic Hospital, Department of Neurology and Stroke
Kisvárda, Hungary · Recruiting
Borsod-Abauj-Zemplen County Central Hospital and University Educational Hospital, Department of Neurology
Miskolc, Hungary · Recruiting
ASST Spedali Civili Brescia
Brescia, Italy · Recruiting
University Hospital "Federico II"
Naples, Italy · Not yet recruiting
University Polyclinic Foundation "Agostino Gemelli" - IRCCS
Rome, Italy · Not yet recruiting
Showing 40 of 81 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.